ACADIA PHARMACEUTICALS INC.
Income Statement
| Line Item | FY2010 | FY2009 |
|---|---|---|
| Revenue | $42.1M | $6.4M |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $20.6M | $41.6M |
| SG&A Expense | $6.5M | $10.3M |
| Operating Income | $15.1M | $-45.5M |
| Operating Margin | 35.8% | -710.5% |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | $12.0K | — |
| Net Income | $15.1M | $-45.1M |
| Net Margin | 35.9% | -705.5% |
| EPS (Basic) | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 38.86B | 37.74B |
| Shares Outstanding (Diluted) | 38.99B | 37.74B |
| Dividends Per Share | — | — |